Osteoporotic bone formation in mice lacking tob2; involvement of Tob2 in RANK ligand expression and osteoclasts

Rieko Ajima1, Toru Akiyama, Michihiko Usui

  • 1The Institute of Medical Science, University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.

FEBS Letters
|March 25, 2008
PubMed

Insights

The antiproliferative gene Tob2 negatively regulates bone loss by suppressing osteoclast formation. Tob2 interacts with the vitamin D receptor to control RANKL expression, impacting bone mass.

Area of Science:

  • Bone Biology
  • Cellular and Molecular Biology
  • Gene Regulation

Background:

  • Tob2 is a member of the antiproliferative gene family.
  • Osteoclasts play a critical role in bone resorption and bone mass regulation.
  • Vitamin D receptor (VDR) signaling influences bone metabolism, including osteoclastogenesis.

Purpose of the Study:

  • To investigate the role of Tob2 in bone metabolism and osteoclast formation.
  • To elucidate the molecular mechanism by which Tob2 regulates osteoclastogenesis.
  • To determine the interaction between Tob2 and the vitamin D receptor (VDR) in regulating RANKL expression.

Main Methods:

  • Analysis of bone mass and osteoclast number in mice lacking Tob2.
  • Overexpression of Tob2 in stromal cells to assess its effect on osteoclast formation.
  • Measurement of RANKL mRNA expression in stromal cells under different Tob2 conditions.
  • Investigation of the interaction between Tob2 and VDR using co-immunoprecipitation or similar techniques.

Main Results:

  • Mice lacking Tob2 exhibited decreased bone mass and increased osteoclast numbers.
  • Overexpression of Tob2 in stromal cells suppressed vitamin D(3)-induced osteoclast formation.
  • RANKL mRNA expression was elevated in Tob2-deficient stromal cells and reduced when Tob2 was present.
  • Tob2 was found to interact with the vitamin D receptor (VDR).

Conclusions:

  • Tob2 negatively regulates osteoclast formation, thereby influencing bone mass.
  • Tob2 suppresses RANKL expression through its interaction with VDR.
  • This interaction suggests Tob2 is involved in VDR-mediated transcriptional regulation impacting bone homeostasis.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
Bone Remodeling and Repair01:31

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...